Cargando…
Targeting ACE2 as a potential prophylactic strategy against COVID-19-induced exacerbation of chronic kidney disease
Patients with chronic kidney disease (CKD) are at higher risk for severe coronavirus disease 2019 (COVID-19). Such patients are more likely to develop “COVID-19-induced acute kidney injury (AKI)”, which exacerbates the pre-existing CKD and increases the mortality rate of the patients. COVID-19-induc...
Autor principal: | Kazama, Itsuro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308890/ https://www.ncbi.nlm.nih.gov/pubmed/35871404 http://dx.doi.org/10.1007/s00011-022-01619-6 |
Ejemplares similares
-
Brain Leukocytes as the Potential Therapeutic Target for Post-COVID-19 Brain Fog
por: Kazama, Itsuro
Publicado: (2023) -
Potential prophylactic efficacy of mast cell stabilizers against COVID-19 vaccine-induced anaphylaxis
por: Kazama, Itsuro
Publicado: (2021) -
ACE2 expression and sex disparity in COVID-19
por: Gagliardi, Maria Cristina, et al.
Publicado: (2020) -
The value of targeting recombination as a strategy against coronavirus diseases
por: Santiago, Enrique, et al.
Publicado: (2020) -
Responsive and agile vaccination strategies against COVID-19 in India
por: Mandal, Sandip, et al.
Publicado: (2021)